Mohsen Rajabi Abhari - FDA Investigator Report

Overview Statistics

34
Total Inspections
8
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 11 days
Shortest Inspection: 3 days
Average Length: 5.1 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Mohsen Rajabi Abhari's Recent Inspections

DateCompanyCityCountryFEI Number483
2020-03-06MEDPHARM LTDGuildfordUnited Kingdom3012675200
2020-02-28Eurofins Pharma Bioanalysis Services Uk LtdAbingdonUnited Kingdom3012157443
2020-01-24Pharma Medica Research, Inc.MississaugaCanada3003228091
2019-12-06QPS Netherlands B.V.GroningenNetherlands3008548421
2019-11-29Melbourn Scientific Limited (d.b.a. Intertek Melbourn)RoystonUnited Kingdom3002807539
2019-11-29Melbourn Scientific Limited (d.b.a. Intertek Melbourn)RoystonUnited Kingdom3002807539
2019-10-18Alkem Laboratories LtdNavi MumbaiIndia3004438419
2019-10-11Mylan Laboratories LtdHyderabadIndia3006355432
2019-08-16Veeda Clinical Research Pvt. Ltd.AhmedabadIndia3006355426
2019-08-09AnaCipher Clinical Research OrganizationHyderabadIndia3007112162

Sign Up to get the complete report.

Download 483s and EIRs for Mohsen Rajabi Abhari

Mohsen Rajabi Abhari - Co-Inspectors

Mohsen Rajabi Abhari's Active Locations

  • India
  • United States
  • United Kingdom
  • Canada
  • Germany
  • Netherlands
  • Israel
  • Spain
  • Switzerland

Mohsen Rajabi Abhari's Year-wise Inspection Count

  • 2016:1 inspections
  • 2017:8 inspections
  • 2018:10 inspections
  • 2019:12 inspections
  • 2020:3 inspections
Last Updated: 2025-05-14 06:11:22